AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27196626
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLL)
Trial: 22777041
Drug: ST-246 400
RxNorm normalized name: STS
DrugBank: Sodium tetradecyl sulfate (DB00464)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ST-246 400 mg and 600 mg
Trial: 20035387
Drug: Risk-adapted treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risk-adapted treatment approach
Trial: 24742226
Drug: Yuzu scent
RxNorm normalized name: ALCOHOL 70 mL in 100 mL TOPICAL SPRAY [The creme shop BT21 MOISTURIZING SANITIZERSpray YUZU SCENTED]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yuzu scent inhalation
Trial: 22704121
Drug: Pelvic plexus
RxNorm normalized name: Bos taurus solar plexus preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pelvic plexus block (2.5 ml lidocaine 1% plus naropine 0.75%) plus intrarectal local anesthesia (lidocaine 1.5%-nifedipine 0.3% cream)
Trial: 28355323
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy based on reflex stimulation (RPT)
Trial: 16552809
Drug: Diuretics alone
RxNorm normalized name: hydralazine hydrochloride / hydrochlorothiazide / reserpine Oral Tablet [Diuretic Ap-Es]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretics alone (group 2)
Trial: 23949578
Drug: Albuterol administration
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol administration
Trial: 16803420
Drug: Amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine 5 or 10 mg/day
Trial: 17703632
Drug: Insulin glulisine
RxNorm normalized name: Insulin Glulisine
DrugBank: Insulin glulisine (DB01309)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Insulin glulisine (Apidra®)
Trial: 18238788
Drug: Control treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatments
Trial: 24946636
Drug: Metformin hydrochloride
RxNorm normalized name: Metformin Hydrochloride
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metformin hydrochloride tablet (0.5 g, once a day for the first week, twice a day from the second week)
Trial: 8026259
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg on weekends (group B)
Trial: 18808445
Drug: Naloxone-3-glucuronide (NX3G)
RxNorm normalized name: MENTHOL GLUCURONIDE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone-3-glucuronide (NX3G) 0.16 mg/kg
Trial: 31067138
Drug: Local Consolidative
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local Consolidative Therapy (LCT)
Trial: 31067138
Drug: Maintenance Therapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance Therapy or Observation (MT/O)
Trial: 30995611
Drug: Half and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half and quarter doses
Trial: 8110568
Drug: Bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.25% 40 ml with morphine 2 mg (group BM2)
Trial: 9387133
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human erythropoietin (rhEPO) given intravenously for 8 weeks at 50 Ul/kg body weight three times a week, then subcutaneously for 4 weeks at 25 Ul/kg body weight twice a week, and for the last 8 weeks at 25 Ul/kg body weight once a week.
Trial: 16532455
Drug: Gabapentin treatment
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gabapentin treatment
Trial: 14551096
Drug: Compliance therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compliance therapy
Trial: 6453571
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy
Trial: 24809976
Drug: Volume-controlled ventilation
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Volume-controlled ventilation with VT 10 ml/kg predicted body weight
Trial: 12947360
Drug: Cholesterol-lowering medication
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholesterol-lowering medication
Trial: 20118170
Drug: Patient engagement
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient engagement in treatment decisions
Trial: 20118170
Drug: Awareness of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Awareness of medication requests
Trial: 20118170
Drug: Patient inquiries
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient inquiries about medication
Trial: 8699068
Drug: SPf66 synthetic
RxNorm normalized name: Camphor (synthetic)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SPf66 synthetic vaccine
Trial: 22633322
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccine
Trial: 23413812
Drug: Commercially pure
RxNorm normalized name: Dream Pure BB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commercially pure titanium narrow diameter implants
Trial: 23413812
Drug: Titanium-zirconium alloy
RxNorm normalized name: zirconium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Titanium-zirconium alloy narrow diameter implants
Trial: 9806503
Drug: Concurrent ChT
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent ChT and hyperfractionated RT (69.6 Gy in 6 weeks)
Trial: 17203523
Drug: Comprehensive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive treatment (Shehuang Paste + Chinese herbal colon dialysis)
Trial: 17203523
Drug: Simple treatment
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simple treatment (Shehuang Paste only)
Trial: 27088471
Drug: Functional Electrical
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Functional Electrical Stimulation (FES) cycling training for 15 days (30 minutes daily for 5 days a week)
Trial: 29743598
Drug: Urinary protein
RxNorm normalized name: Urinary protein of low molecular weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urinary protein excretion (≥ 3.5 g/d)
Trial: 15342612
Drug: Curative ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Curative ibuprofen (same dosage regimen as prophylactic)
Trial: 8299455
Drug: Regular insulin
RxNorm normalized name: Regular insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular insulin injected subcutaneously in the abdomen
Trial: 10593347
Drug: US 3
RxNorm normalized name: RUS 3108
DrugBank: RUS 3108 (DB05911)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: US 3 G: 1 g of stanol (ester form) per 8‐g serving of a US reformulation 3 times a day
Trial: 28527420
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (NAC) followed by surgery with or without radiotherapy.
Trial: 8525777
Drug: Subunit influenza
RxNorm normalized name: covid-19, protein subunit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subunit influenza vaccine (15 micrograms of each haemagglutinin strain)
Trial: 9735587
Drug: Delayed-treatment control
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed-treatment control
Trial: 27603424
Drug: Alternating therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternating therapy with MMC and BCG
Trial: 10202830
Drug: Nandrolone decanoate
RxNorm normalized name: Nandrolone Decanoate
DrugBank: Nandrolone decanoate (DB08804)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nandrolone decanoate 195 mg weekly
Trial: 12841885
Drug: Transdermal estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal estrogen (50 microg/day) and medroxyprogesterone acetate (5 mg/day) continuously
Trial: 29973224
Drug: Iron isomaltoside
RxNorm normalized name: Iron isomaltoside 1000
DrugBank: Iron isomaltoside 1000 (DB12208)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron isomaltoside 1000 (IVFe) administered intravenously 1000 mg (maximum dose 20 mg/kg) 3 days before and after surgery
Trial: 15804075
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline solution (Control)
Trial: 19906075
Drug: Alitretinoin 10
RxNorm normalized name: Alitretinoin
DrugBank: Alitretinoin (DB00523)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alitretinoin 10 mg once daily for 12-24 weeks
Trial: 10539123
Drug: Intravenous ganciclovir
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ganciclovir (5 mg/kg/day)
Trial: 1743712
Drug: Podophyllin resin
RxNorm normalized name: podophyllin
DrugBank: Podophyllin (DB09094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Podophyllin resin 25% applied to lesions twice weekly for up to six weeks
Trial: 6107725
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg DAMME (FK33-824, Sandoz) infusion
Trial: 7135
Drug: Cimetidine 200
RxNorm normalized name: cimetidine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 200 mg
Trial: 16154480
Drug: Valsartan 160
RxNorm normalized name: valsartan 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 160 mg OD (V160)
Trial: 16154480
Drug: Valsartan 160
RxNorm normalized name: valsartan 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 160 mg OD plus Hydrochlorothiazide 12.5 mg OD (V160 + HCTZ12.5)
Trial: 2265733
Drug: Continuous subcutaneous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous subcutaneous insulin infusion pump therapy (CSII)
Trial: 27159624
Drug: Group M
RxNorm normalized name: Coenzyme M
DrugBank: Coenzyme M (DB09110)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group M (0.05 mg/kg midazolam)
Trial: 7746058
Drug: Simvastatin therapy
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simvastatin therapy
Trial: 8986917
Drug: Valsartan 80
RxNorm normalized name: valsartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 80 mg once a day
Trial: 1335643
Drug: Vaccine-induced antibodies
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine-induced antibodies after booster dose
Trial: 20560291
Drug: Inhaled iloprost
RxNorm normalized name: iloprost Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled iloprost (5 mcg every 2-3 hours while awake)
Trial: 7635769
Drug: Stage IIB
RxNorm normalized name: SAGE
DrugBank: Sage (DB10982)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stage IIB treatment duration < 55 days
Trial: 8339809
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 1 mg/day
Trial: 8339809
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate 2 mg/day
Trial: 18509786
Drug: Pharmacological closure
RxNorm normalized name: COPD pharmacologic substance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacological closure (NSAIDs treatment)
Trial: 22515886
Drug: 1.9 mL
RxNorm normalized name: 1.9 ML Elrexfio 40 MG/ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.9 mL of lidocaine (76.4 mg) with epinephrine plus 0.5 mol/L mannitol
Trial: 28947725
Drug: Dual antiplatelet
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual antiplatelet therapy accompanied by oral anticoagulation (OAC) - triple therapy
Trial: 20101008
Drug: Orlistat therapy
RxNorm normalized name: Orlistat
DrugBank: Orlistat (DB01083)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Orlistat therapy plus low-fat diet (O + LFD)
Trial: 15867009
Drug: Intramuscular testosterone
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular testosterone enanthate (100 mg weekly) plus oral levonorgestrel (31.25 microg daily)
Trial: 6833466
Drug: Dermorphin during
RxNorm normalized name: Pro-C-Dure 6 Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dermorphin during naloxone infusion
Trial: 2797920
Drug: Pressurized aerosol
RxNorm normalized name: tetracaine
DrugBank: Tetracaine (DB09085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pressurized aerosol (2 mg terbutaline)
Trial: 29492934
Drug: Diclofenac 75
RxNorm normalized name: CAPSAICIN 0.025%/DICLOFENAC 75MG KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 75 mg
Trial: 26874901
Drug: Neratinib 240
RxNorm normalized name: NERATINIB
DrugBank: Neratinib (DB11828)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Neratinib 240 mg per day
Trial: 17684876
Drug: Granisetron 1
RxNorm normalized name: granisetron 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron 1 mg plus Droperidol 1.25 mg
Trial: 17684876
Drug: Granisetron 1
RxNorm normalized name: granisetron 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron 1 mg plus Dexamethasone 8 mg
Trial: 22440125
Drug: Increase in
RxNorm normalized name: Incruse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increase in urinary albumin excretion (UAE) of 2 logs at 1 year
Trial: 22306735
Drug: Hormone receptor-positive
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone receptor-positive disease
Trial: 1575174
Drug: Nifedipine SR
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine SR 20 mg
Trial: 18094220
Drug: clarithromycin 500
RxNorm normalized name: clarithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: clarithromycin 500 mg bid
Trial: 11397620
Drug: ofloxacin 400
RxNorm normalized name: ofloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ofloxacin 400 mg bid
Trial: 9310602
Drug: Weekly Deltaprim
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly Deltaprim (malaria prophylaxis)
Trial: 18008241
Drug: Monthly IPTp
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly IPTp (sulfadoxine-pyrimethamine)
Trial: 8576675
Drug: Clinacanthus nutans
RxNorm normalized name: Streptococcus mutans
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinacanthus nutans extract applied five times daily for 7-14 days
Trial: 31399915
Drug: Early combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early combination therapy with gentamicin (treatment started within 48 hours of culture results and continued for a minimum of 7 days)
Trial: 28686664
Drug: Lower dose
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower dose of hydrocortisone (0.2-0.3 mg HC/kg body weight/day)
Trial: 28686664
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose of hydrocortisone (0.4-0.6 mg HC/kg body weight/day)
Trial: 23374199
Drug: Strain-counterstrain treatment
RxNorm normalized name: Haemagglutinin-strain B
DrugBank: Haemagglutinin-strain B (DB15482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strain-counterstrain treatment after full osteopathic treatment
Trial: 21675956
Drug: Gene therapy
RxNorm normalized name: E1A gene therapy
DrugBank: RGG0853 (DB18669)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gene therapy using plasmidial constructs expressing vascular endothelial and hepatocyte growth factors
Trial: 26086603
Drug: High loading
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High loading dose of Rosuvastatin before PCI
Trial: 17978591
Drug: Metoprolol tartrate
RxNorm normalized name: Metoprolol Tartrate
DrugBank: Metoprolol (DB00264)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metoprolol tartrate 50 to 200 mg bid
Trial: 19773619
Drug: Bone cement
RxNorm normalized name: bone cement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone cement augmentation (Group 1, n=12)
Trial: 3391878
Drug: Erythromycin acistrate
RxNorm normalized name: Erythromycin
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin acistrate (EA) 500 mg tid for three days
Trial: 3391878
Drug: Erythromycin base
RxNorm normalized name: Erythromycin base
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin base (EB) enterotablets 500 mg tid for three days
Trial: 15336467
Drug: Immediate-release oxybutynin
RxNorm normalized name: oxybutynin Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release oxybutynin (TID)
Trial: 11876710
Drug: Post-drug withdrawal
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-drug withdrawal
Trial: 3391878
Drug: Erythromycin base
RxNorm normalized name: Erythromycin base
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin base (EB) enterocapsules 500 mg tid for three days
Trial: 3391878
Drug: Erythromycin stearate
RxNorm normalized name: Erythromycin Stearate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin stearate (ES) 500 mg tid for three days
Trial: 9632571
Drug: Cellular vaccine
RxNorm normalized name: PERTUSSIS VACCINE,ACELLULAR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cellular vaccine
Trial: 28489468
Drug: Betamethasone dipropionate
RxNorm normalized name: Betamethasone Dipropionate
DrugBank: Betamethasone (DB00443)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone dipropionate (BD) ¼ dilution (1.25 mg/dL)
Trial: 16417774
Drug: Fenbid Capsules
RxNorm normalized name: fenbid
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fenbid Capsules 0.3 g twice a day and Tripterygium tablet 20 mg thrice a day for 6 weeks
Trial: 21671456
Drug: Dronabinol 20
RxNorm normalized name: Dronabinol
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dronabinol 20 mg
Trial: 26483357
Drug: Dronabinol 30
RxNorm normalized name: Dronabinol
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dronabinol 30 mg
Trial: 21671456
Drug: Dronabinol 40
RxNorm normalized name: Dronabinol
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dronabinol 40 mg
Trial: 26483357
Drug: Dronabinol 5
RxNorm normalized name: dronabinol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dronabinol 5 mg
Trial: 8858268
Drug: Cilazapril 2.5
RxNorm normalized name: cilazapril 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilazapril 2.5 mg daily
Trial: 22867539
Drug: Paracetamol 1
RxNorm normalized name: Paracetamol 1 g oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 1 g and ketorolac 20 mg intravenously
Trial: 3122628
Drug: TTS NG
RxNorm normalized name: NG
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TTS NG 10 mg/24 h
Trial: 1643799
Drug: Porcine Insulin
RxNorm normalized name: Porcine insulin
DrugBank: Insulin pork (DB00071)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Porcine Insulin (PI)
Trial: 12095665
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of oral cocaine HCl
Trial: 2003340
Drug: Intravenous ofloxacin
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ofloxacin
Trial: 27681702
Drug: Rivastigmine patch
RxNorm normalized name: Rivastigmine
DrugBank: Rivastigmine (DB00989)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Rivastigmine patch (5 cm2 [4.6 mg/24 h], 10 cm2 [9.5 mg/24 h], 15 cm2 [13.3 mg/24 h], and 20 cm2 [17.4 mg/24 h])
Trial: 23445266
Drug: Intercostal nerve
RxNorm normalized name: nerve growth factor
DrugBank: Nerve Growth Factor (DB12620)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intercostal nerve blockade with 20 mL of 0.5% bupivacaine with epinephrine
Trial: 16979453
Drug: Patient phone
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient phone call to assess smoking status, quit challenges, and treatment preferences, and computerized progress note to providers communicating this information
Trial: 2498074
Drug: Carbamazepine (CBZ)
RxNorm normalized name: Carbamazepine
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbamazepine (CBZ) suspension administered orally after an overnight fast